A mouse study by German and Israeli researchers, published in 2024, found that long-term low-dose THC affected mTOR signalling and metabolic compounds differently across tissues. It helps investigate ageing-related mechanisms but does not show that cannabis slows human ageing or improves memory. Our cannabinoid comparison (in Estonian) explains THC and CBD.
What did researchers test in mice?

In work led by University of Bonn researchers, mice received low-dose THC over 28 days. The analysis included brain mTOR signalling, which relates to cellular metabolism and protein synthesis, and metabolic indicators in blood plasma and fat tissue.
One notable finding concerned mTOR activity: in certain brain regions, it temporarily increased early in treatment, while fat tissue and metabolic measures showed different changes. The authors interpreted this as suggesting that THC’s effects may vary by tissue.
Why does this not justify an anti-ageing recommendation?
mTOR is a complex signalling pathway. Increasing or reducing its activity may have different outcomes depending on tissue, timing and an organism’s condition. Changes in individual molecular markers do not independently establish longer life or improved health.
The experiment involved mice, rather than people. Animal doses, life stages and metabolism cannot be transferred directly to human cannabis use. Nor does the work justify recommending THC to older adults for memory: effects may depend on dose and carry adverse-effect risks.
What does the research contribute?
It suggests possible mechanisms to test in further animal studies and carefully designed clinical trials. This is relevant basic research on cannabinoids and ageing biology, rather than evidence of an available anti-ageing treatment.
Original sources: Bilkei-Gorzo and colleagues, “Bidirectional Effect of Long-Term Δ9-Tetrahydrocannabinol Treatment on mTOR Activity and Metabolome”, ACS Pharmacology & Translational Science, 2024, and the University of Bonn’s research summary.
Illustrative featured photograph: Edward Jenner / Pexels (Pexels License).